ABSTRACT
BACKGROUND: Bloodstream infections (BSI) are a global health issue, leading to high mortality and morbidity among hospitalized patients. METHODS: A retrospective, observational and descriptive study was conducted by reviewing blood culture records collected from patients with suspected BSI, between January 2017 and December 2019. RESULTS: The most frequent antimicrobial resistant (AMR) pathogens were methicillin-resistantStaphylococcus aureus(MRSA) (40%), methicillin-resistantS. epidermidis (MRSE) (9.5%), and extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae (35.3%). CONCLUSIONS: Our findings underscore the importance of continued vigilance and advocate for the rational use of antimicrobial agents.
Subject(s)
Anti-Infective Agents , Bacteremia , Cross Infection , Methicillin-Resistant Staphylococcus aureus , Sepsis , Humans , Anti-Bacterial Agents/pharmacology , Bacteremia/microbiology , beta-Lactamases , Brazil , Cross Infection/microbiology , Drug Resistance, Bacterial , Methicillin , Retrospective Studies , Sepsis/microbiology , Tertiary Care CentersABSTRACT
ABSTRACT Background: Bloodstream infections (BSI) are a global health issue, leading to high mortality and morbidity among hospitalized patients. Methods: A retrospective, observational and descriptive study was conducted by reviewing blood culture records collected from patients with suspected BSI, between January 2017 and December 2019. Results: The most frequent antimicrobial resistant (AMR) pathogens were methicillin-resistantStaphylococcus aureus(MRSA) (40%), methicillin-resistantS. epidermidis (MRSE) (9.5%), and extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae (35.3%). Conclusions: Our findings underscore the importance of continued vigilance and advocate for the rational use of antimicrobial agents.
